1mg~2mg x 1wk (expected sensitivity to warfarin)
for what population
> 75y
High bleeding rsk
CHF
Liver or kidney disease
Poor nutritional status
low albumin level
Baseline INR not within 0.8-1.2 , possible clotting deficiency
Indian, overweight (lower INR – HIGHER dose needed)
Current thyroid storm, infection, CYP inh (higher iNR - lower dose now)
When to add clexane with initiating warfarin
ACE, VTE, bridging OAC with mechanical heart/valves/ high TE risk/ active clot (complete 5d bridging!)
high TE risk
AF with CHADVASC ≥7
AF with stroke/ TIA
recurrent stroke or <3m
mechanical valve replacement
intracardiac thrombus
rheumatic mitral stenosis
recurrent VTE or <3m
chronic TE pulmonary HTN, arterial thromboembolism, artificial bypass graft
APS, deficiency clots
moderate TE
non-valvular AF CHADVASC 5-6
VTE within 3-12m
low TE
non-valvular AF CHADVASC <4, no stroke
stroke without AF >9m
VTE >12m
Pt bleeding risk - HIGH
procedure with high bleed risk
severe renal impairment/ liver
hx of bleeding: anemia, thrombocytopenia, bleed event within 3m
active cancer
>75y
high vs mod TE clexane dose
High TE: therapeutic dose 1mg/kg BD or OD based on crcl
Mod TE: prophylactic dose 40mg or 30mg based on crcl
warfarin > DOAC, LMWH, IV heparin
INR <2 stop warfarin, start DOAC
INR2-3 stop warfarin, start DOAC 1 DAY AFTER
INR>3, repeat INR
dabig > warfarin
crcl > 50, start warfarin 3d after stopping dabig
crcl 30-50, start warfarin 2d after stopping dabig
rivaox > warfarin
stop rivarox, start clexane
INR >2
apix > warfarin
concurrent for 2d
INR 3rd day, until >2
INR goals 2.5-3.5
mechanical Mitral replacement
Risk factors for thromboembolism (AF, anterior-apical STEMI, left atrial enlargement, hypercoagulable state, low EF)
short term warfarin
bioprosthetic mitral valve replacement (3m > aspirin 100mg/d)
until thrombus resolves
Large anterior MI, significant heart failure,
intracardiac thrombus, AF, history of
thromboembolic event (3m)
DVT, PE (provoked 3-6m), (unprovoked 6-12m)
Dabigatran dose AF
CrCl >30 mL/min:
150mg twice daily
If age ≥80 years:
110mg twice daily
CrCl <30 ml/min:
Avoid use
dabig DVT
CrCl > 30ml/min:
Parenteral anticoagulant x 5-10 days then 150mg twice daily
dabig prophy dose
CrCl >30 mL/min:
150 mg twice daily
rivarox AF dose
CrCl > 50ml/min:
20mg once daily
CrCl 15-50 ml/min:
15mg once daily
CrCl <15 ml/min:
Avoid use
rivarox DVT dose
CrCl ≥ 30ml/min:
15mg twice daily x 21
days then 20mg once
daily
rivarox prophy dose
CrCl ≥ 30ml/min:
10mg once daily
We do not have the 10mg tablet. (½ of 20mg tablet)
The 2.5mg dose is for pts that have Peripheral Artery Disease done stenting, for DAT (Dual Antithrombotic Therapy).
apix AF
CrCl > 30ml/min:
5mg twice daily
Fulfill at least 2 of the
following:
Age ≥80 years
Body weight ≤60kg
Serum creatinine ≥133umol/L
2.5mg twice daily
CrCl 15-30ml/min:
2.5mg twice daily
CrCl <15 ml/min:
Avoid use
apix DVT tx dose
crCl > 25ml/min:
10mg twice daily x 7 days
then 5mg twice daily
Apix prophy
CrCl > 25ml/min:
2.5mg twice daily
pain
incr INR
hepatic impairment
incr INR
Decreased clotting factor synthesis and warfarin metabolism